Hims & Hers (HIMS) Chief Legal Officer awarded 188,111 RSUs in equity grant

Rhea-AI Filing Summary

Boughton Soleil reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that Chief Legal Officer Soleil Boughton received a grant of 188,111 Restricted Stock Units (RSUs), each representing a right to one share of Class A common stock. The RSUs vest over four years in substantially equal quarterly installments, beginning on June 15, 2026, with vesting dates on March 15, June 15, September 15 and December 15.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Boughton Soleil

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	188,111	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 188,111 shares (Direct)

Footnotes (1)

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/11/2026		A		188,111		(2)	(2)	Class A Common Stock	188,111	$0	188,111	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hims & Hers (HIMS) disclose for Soleil Boughton?

Hims & Hers disclosed that Chief Legal Officer Soleil Boughton received a grant of 188,111 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Class A common stock, providing equity-based compensation tied to future service with the company.

How many RSUs did the Hims & Hers Chief Legal Officer receive in this Form 4?

The Chief Legal Officer received 188,111 Restricted Stock Units. These RSUs were granted at a price of $0.00 per unit and convert into an equal number of Class A common shares as they vest over the specified four-year vesting schedule.

What is the vesting schedule for the 188,111 RSUs reported by Hims & Hers (HIMS)?

The 188,111 RSUs vest over a four-year period in substantially equal quarterly installments. Vesting occurs on March 15, June 15, September 15 and December 15, with the first vesting date on June 15, 2026, contingent on satisfying service-based requirements.

Does the RSU grant to the Hims & Hers Chief Legal Officer involve any purchase price?

The RSU grant carries a transaction price of $0.00 per unit. The award is compensation-based, representing a contingent right to receive Class A common shares upon vesting, rather than an open-market purchase of stock for cash consideration by the executive.

What does each Hims & Hers RSU reported in this filing represent?

Each Restricted Stock Unit represents a contingent right to receive one share of Hims & Hers Class A Common Stock. The shares are only delivered as the RSUs vest over time, aligning the Chief Legal Officer’s compensation with ongoing service and long-term company performance.

How many Hims & Hers RSUs does Soleil Boughton hold after this transaction?

Following this grant, Soleil Boughton holds 188,111 Restricted Stock Units. These units are derivative securities that will settle into an equal number of Class A common shares as they vest, assuming the service-based vesting conditions are satisfied over the four-year schedule.